Velocity Clinical Research has expanded its European senior executive team. Évelyne Newton joins as Vice President of Business Development, Sandra Stark as Vice President of European Operations and Maria Lehretz is the new Medical Director.
MMS Holdings announced the appointment of Chris Schoonmaker as Chief Operating Officer and Ashu Tandon as Chief Commercial Officer.
Sunitha Mathew, MS, has joined Westat's leadership team as its new Clinical Research Practice Director.
Clinical ink announced that healthcare industry veteran Jonathan Goldman MD has joined the company as Chief Executive Officer.
Vakzine Projekt Management GmbH announced the successful completion of a clinical client project with AntiBKV, an antibody targeting BK polyomavirus infection in renal transplant patients, for Memo Therapeutics AG, Switzerland.
Spaulding Clinical announced early results for a clinical trial as a part of the FDA’s proactive effort to address the opioid crisis and reduce opioid overdoses and deaths.
Verisense Health, Inc. announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff.
Medidata announced it was positioned as a Leader in the IDC MarketScape “Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment (doc #US48061722).”
OCT Clinical announced they have successfully completed the enrollment of 3,000 patients in a COVID-19 vaccine study.
Almac Group has won six CDMO Leadership Awards for 2023: Excellence in Capabilities (Small Pharma), Compatibility (Overall and Small Pharma), Expertise (Overall and Small Pharma), Quality (Overall and Small Pharma), Reliability (Overall and Small Pharma), and Service (Small Pharma).
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.